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Abstract 
Background: Similarly to the periodic table for elements, chemical space offers an organizing principle for represent‑
ing the diversity of organic molecules, usually in the form of multi‑dimensional property spaces that are subjected to 
dimensionality reduction methods to obtain 3D‑spaces or 2D‑maps suitable for visual inspection. Unfortunately, tools 
to look at chemical space on the internet are currently very limited.
Results: Herein we present webDrugCS, a web application freely available at www.gdb.unibe.ch to visualize Drug‑
Bank (www.drugbank.ca, containing over 6000 investigational and approved drugs) in five different property spaces. 
WebDrugCS displays 3D‑clouds of color‑coded grid points representing molecules, whose structural formula is 
displayed on mouse over with an option to link to the corresponding molecule page at the DrugBank website. The 
3D‑clouds are obtained by principal component analysis of high dimensional property spaces describing constitution 
and topology (42D molecular quantum numbers MQN), structural features (34D SMILES fingerprint SMIfp), molecular 
shape (20D atom pair fingerprint APfp), pharmacophores (55D atom category extended atom pair fingerprint Xfp) 
and substructures (1024D binary substructure fingerprint Sfp). User defined molecules can be uploaded as SMILES 
lists and displayed together with DrugBank. In contrast to 2D‑maps where many compounds fold onto each other, 
these 3D‑spaces have a comparable resolution to their parent high‑dimensional chemical space.
Conclusion: To the best of our knowledge webDrugCS is the first publicly available web tool for interactive visualiza‑
tion and exploration of the DrugBank chemical space in 3D. WebDrugCS works on computers, tablets and phones, 
and facilitates the visual exploration of DrugBank to rapidly learn about the structural diversity of small molecule 
drugs.
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Background
One of the defining features of organic chemistry is the 
extremely large diversity of possible molecules. The con-
cept of chemical space, whereby molecules are annotated 
with a set of quantitative molecular properties and placed 
in a high-dimensional property space with each dimen-
sion corresponding to a different property, offers a prac-
tical approach to represent the structural diversity of 
large molecule collections [1–28]. Such high-dimensional 
spaces cannot be visualized directly but can be subjected 
to various dimensionality reduction methods to obtain 
3D-spaces or 2D-maps suitable for visual inspection 
[29–32].
To make chemical space easier to inspect, we recently 
reported an interactive Java Applet representing databases 
of molecules as color-coded maps produced by projec-
tion of high-dimensional property spaces, defined by vari-
ous molecular fingerprints, into two dimensions [32–37]. 
In these so-called Mapplets the computer screen shows 
a color-coded 2D-image where each pixel contains one 
or several molecules projected at that point. The average 
molecule contained in each pixel is displayed on a side-
window on mouse over, with an option to open the com-
plete list of molecules in the pixel in a secondary window, 
and subsequently to link selected molecules to the data-
base entry, or to perform similarity searches in the parent 
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high-dimensional property space. These Mapplets unfor-
tunately suffer from the typical folding effects encountered 
when projecting high-dimensional property spaces into 
2D [2, 6, 9, 28, 30, 32], which results in (a) many pixels con-
taining molecules piled-up on top of each other, and (b) 
a poor correlation between distances on the 2D-map and 
distances in the original high-dimensional property space. 
In addition the Java Applets must be downloaded and run 
separately and are not platform independent.
Herein we report webDrugCS, a web application freely 
accessible at www.gdb.unibe.ch which addresses these 
limitations by enabling access to molecules via interac-
tive color-coded 3D-spaces in a manner similar to the 
2D-mapplet. The website visualizes DrugBank (http://
www.drugbank.ca/), a public database listing over 6000 
compounds currently in medical use either as FDA 
approved and marketed drug or as investigational drugs 
[38]. Similarly to our recently reported PDB-Explorer 
website to visualize the Protein Databank [39], web-
DrugCS uses the internet browser of the user to gener-
ate the display. DrugBank is represented in the form of 
color coded 3D-spaces obtained by principal component 
analysis (PCA) of five different multidimensional prop-
erty spaces defined by five different fingerprints. These 
fingerprints describe constitution and topology (42D 
molecular quantum numbers, MQN), structural fea-
tures (34D SMILES fingerprint SMIfp), molecular shape 
(20D atom pair fingerprint APfp), pharmacophores (55D 
atom category extended atom pair fingerprint Xfp) and 
substructures (1024D binary substructure fingerprint 
Sfp) (Table  1). The 3D-spaces are generated using three.
js (http://threejs.org/), an open-source JavaScript library/
API for animated 3D computer graphics in a web browser. 
Although less sophisticated than other chemical space 
visualization tools designed to assess compound collec-
tions [40–46], webDrugCS provides an unprecedented 
tool to look at DrugBank and rapidly learn about the 
structural diversity of small molecule drugs. This feature 
is not offered at the DrugBank website and at any other 
currently available online tools such as eDrug3D [47], 
SuperDrug [48], SuperPred [49], or BalestraWeb [50], 
which are primarily designed to address specific queries 
such as drug name, substructure, molecular formula or 
protein target by providing a limited number of answers.
Results and discussion
PCA of multidimensional property spaces
In a multidimensional property space dimensions and the 
position (coordinates) of any molecule are defined by a set 
of molecular descriptors. PCA is performed as a dimen-
sionality reduction method to obtain 3D- or 2D-represen-
tations. In these projections the position of any molecule is 
defined by its coordinates in the first three respectively two 
principal components (PCs). Here PCA is used to project 
DrugBank from each of the five property spaces defined by 
the fingerprints MQN, SMIfp, APfp, Xfp and Sfp onto the 
corresponding 3D-space or 2D-map. The cumulative cov-
erage of data variance within the first 3 PCs is larger than 
75 % in the case of the fingerprints MQN, SMIfp and APfp, 
which are relatively simple descriptions of the molecules 
resulting in a relatively low number of dimensions (Fig. 1a). 
In these cases a very good correlation is observed between 
distances in the original high-dimensional property space 
and the 3D-projection (Fig. 1b). The situation is less opti-
mal for the more complex and higher dimensional finger-
prints Xfp and Sfp, where only 42 % respectively 20 % of 
data variance is covered within the first three PCs. Nev-
ertheless the correlation between distances in the origi-
nal property space and the 3D-space resulting from PCA 
is still acceptable (Xfp: 0.8, Sfp: 0.6), implying that these 
3D-spaces still contain relevant information about the posi-
tion of molecules in the original high-dimensional Xfp and 
Sfp spaces. In particular nearest neighbours in each of the 
3D spaces are for the most part closely related molecules in 
the corresponding high-dimensional property space.
One of the remarkable aspects of the 3D-spaces con-
cerns the resolution of compounds into individual 3D-grid 
positions after assigning molecules to a 3D-grid point in 
a 300 × 300 × 300 box covering the range of (PC1, PC2, 
PC3) values. In the original multidimensional property 
Table 1 Fingerprints used in this study
Fingerprint Feature perceived Description References
MQN Composition 42D scalar fingerprint, counts 42 molecular quantum numbers (MQN) counting atom types, bond 
types, polar groups and topologies
[51, 52]
SMIfp Composition 34D scalar fingerprint, counts 34 characters appearing in the SMILES notation of molecules [35]
APfp Shape 20D scalar fingerprint, each dimension counts the number of atom pairs at one particular topological 
distance between 1 and 20 bonds, normalized to HAC
[53]
Xfp Pharmacophore 55D scalar fingerprint, category extended version of APfp counting the number of category atom 
pairs at one particular topological distance between 0 and 10 bonds, normalized to the number of 
category atoms, for categories: hydrophobic atoms, H‑bond donor atoms, H‑bond acceptor atoms, 
sp2 hybridized atoms, and HBA/HBD cross‑pairs
[53]
Sfp Substructure 1024D binary fingerprint, perceives the presence of substructures [54]
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spaces an excellent resolution is obtained for DrugBank in 
the sense that almost all DrugBank molecules are encoded 
by a unique fingerprint bit value combination. This resolu-
tion is largely preserved upon PCA and assignment to the 
3D-grid, as can be judged by the fact that the percentage of 
molecules appearing in singly occupied 3D-grid points is 
comparable to the percentage of molecule having a single 
fingerprint bit-value combination. The 3D-space is clearly 
superior in that matter to the 2D-map, where compounds 
are assigned to 2D-pixels in a 300 × 300 square covering 
the range of (PC1, PC2) values. In this case a significant 
folding occurs and only 40–60 % of the compounds appear 
in single occupied 2D-pixels (Fig. 1c).
As an additional noticeable feature the 3D-represen-
tations of the various property spaces represent Drug-
Bank an intuitively logical spatial organization which 
can be visualized by color-coding each grid-point with 
a selected property value. As illustrated by screen-shots 
taken from the web application webDrugCS (details dis-
cussed below), striking features include for example 
parallel stripes grouping compounds of increasing ring 
count in the MQN 3D-space (Fig. 2a), the separation of 
molecules according to their number of aromatic carbon 
atoms in the SMIfp 3D-space (Fig. 2b) and according to 
their rotatable bond count in the APfp 3D-space (Fig. 2c), 
and the global separation of the Sfp 3D-space according 
to the fraction of aromatic atoms (Fig. 2d).
webDrugCS
WebDrugCS (www.gdb.unibe.ch) is an online application 
for interactive visualization and exploration of DrugBank 
in color coded 3D property spaces. The application works 
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Fig. 1 Analysis of the DrugBank database. a Percentage of data variance covered by increasing numbers of PC obtained by PCA of MQN‑, SMIfp‑, 
APfp‑, Xfp‑ and Sfp‑datasets of DrugBank. b Pearson’s correlation coefficient between pairwise euclidean distances in the n‑dimensional PC‑
subspace and the respective original MQN, SMIfp, APfp, Xfp and Sfp fingerprint spaces, calculated from analyzing 36 M molecule pairs in the 
DrugBank database. c Percentage of the DrugBank database considering all single occupied bins in the original fingerprint space (black), grid points 
in 3D‑space (blue) and pixels in 2D‑space (red). A bin is defined as one particular fingerprint value combination. The 3D‑spaces were generated 
by projecting DrugBank onto a grid of 300 × 300 × 300 grid points. The 2D‑maps were generated by projecting the DrugBank onto a map of 
300 × 300 pixels
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on computers, tablets and phones. The starting page of 
webDrugCS (Fig.  3a) provides two options (1) Selection 
of molecular fingerprint: Choose between MQN, SMIfp, 
APfp, Xfp and Sfp fingerprint 3D-spaces by clicking the 
corresponding field, which opens a new browser tab. (2) 
External chemical library: The user can input up to 1000 
additional molecules in SMILES format, which will be 
displayed together with DrugBank in any of the selected 
3D-spaces. Each of the lines in the text box must rep-
resent an individual molecule as SMILES followed by a 
space and its name or tag. External molecules are viewed 
by default as dark violet colored grid points.
The graphical user interface (GUI) of the interactive 
visualization window is exemplified here with the MQN 
3D-space. The GUI consists of a main panel, a molecule 
view panel, and a control panel. The main panel occupies 
the entire screen area and displays the 3D-space (Fig. 3b). 
Each point in the 3D-space is represented as sphere, 
whose size depends on its distance to the camera. The 
view angle rotates by dragging the mouse upon left click, 
and the wheel controls the zoom in/out function.
The view panel is positioned at upper left and shows 
the structural formula and DrugBank ID of the molecule 
at the current mouse-over 3D-grid point. Upon select-
ing a grid point by double click, one can then link to the 
molecule page at the DrugBank webpage by clicking on 
the DrugBank ID displayed below the structural formula 
(Fig. 3c), or access a similarity browser to search for near-
est neighbours in the original high-dimensional finger-
print space via the control panel (Fig. 3d/e).
The control panel at top right lists options to change the 
3D-space view. Lines 1–3: select a color code according 
Fig. 2 Color coded 3D‑spaces of the DrugBank chemical space obtained by taking snapshots from the webDrugCS website (www.gdb.unibe.
ch). The color changes in the range blue → cyan → green → yellow → red → magenta with increasing property value. a MQN 3D‑space color 
coded by ring count, shown with open control panel b SMIfp 3D‑space color coded by the number of aromatic carbon atoms. c APfp 3D‑space 
color coded by rotatable bond count. d Sfp 3D‑space color coded by the fraction of aromatic atoms. The molecule shown in the viewer window is 
located in the mouse over pixel, which is marked as a white sphere in the image
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Fig. 3 The webDrugCS website and its functionalities. a Starting page of the webDrugCS. MQN, SMIfp, APfp, Xfp and Sfp 3D‑spaces of the Drug‑
Bank database can be accessed by clicking on respective buttons. A list of molecules to be mapped on any 3D‑space of the DrugBank database 
can be entered (format: SMILES) into the text box provided in the lower part of the page. See main text for the exact input format and details. b 
Interactive visualization window for MQN 3D‑spaces obtained by clicking the button corresponding to MQN in the starting page. The 3D‑space is 
shown with color coding using HBA atom count. On mouse over the panel at top left displays the molecule at the corresponding grid point. The 
example shown is cyproheptadine. c The DrugBank page for cyproheptadine was obtained by clicking the drug code displayed in the left panel in b. 
d Multifingerprint browser window for DrugBank with the cyproheptadine as query, obtained by clicking the “Link to browser” option in the control 
panel (top right panel in b). e Results window displaying the MQN‑nearest neighbors of the query cyproheptadine in DrugBank
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to a descriptor, or a single color code for DrugBank and 
the uploaded molecule list. Line 4: display the reference 
3D-axes. Line 5: hide the DrugBank grid points, leaving 
only the molecules uploaded by the user as visible points. 
Line 6: change the 3D-grid point sphere size. Line 7: set 
the currently selected 3D-grid point as reference pivot 
point for the 3D-space (after selecting a grid point by 
double click). Line 8: Reset the view to the default entry 
view. Line 9: Link to the fingerprint similarity browser, 
which opens as an additional tab. This browser allows 
one to perform nearest neighbour searches in DrugBank 
in any of the five original high-dimensional fingerprint 
spaces. The browser is built in the same manner as our 
recently reported ChEMBL similarity browser [32]. Line 
10: help function listing the different options.
The external chemical library option in the entry 
panel (Fig.  3a) is illustrated here for mapping 24 drugs 
from DrugBank annotated in ChEMBL as β1-adrenergic 
receptor antagonists. These typical drugs contain a short 
aliphatic amine or aminoalcohol connected to a mono- or 
bicyclic aromatic nucleus. Due to their comparable over-
all composition, molecular shape, pharmacophore and 
substructural elements these 20 drugs form a relatively 
tight group in each of the five property spaces in web-
DrugCS (Fig. 4). In general series of structurally related 
molecules appear grouped in the various 3D-spaces 
available with webDrugCS. Note that the option “hid-
eDB” in the control panel allows one to remove the drug-
bank compounds, which leaves only the external library 
as visible points.
Conclusion
webDrugCS represents the first online application for 
visualizing DrugBank in five different 3D property 
spaces on computers, tablets or phones. In contrast to 
the other database exploration tools, webDrugCS can 
be used for curiosity driven exploration independently 
of specific queries, and is particularly suitable to rapidly 
gain an overview of the structures of drug molecules. 
While the present web-based application is currently 
limited to displaying of a few thousand points, the 
method might be applicable to displaying larger data-
bases of millions of molecules if significant coding pro-
gress can be made.
Methods
Databases The DrugBank database was downloaded in 
SDF format from http://www.drugbank.ca/. Molecules 
were processed by checking for valency error, removing 
counter ions and adjusting their ionization state to pH 
7.4, using an in-house built java program utilizing Java 
Chemistry library (JChem) from ChemAxon, Pvt. Ltd., as 
Fig. 4 Mapping of 20 DrugBank comopunds annotated with β1‑adrenergic receptor antagonist activity in ChEMBL using the extrenal library option 
in webDrugCS. The 20 extrenal compounds are shown as white dots, overlayed on DrugBank shown in color‑coded representation. Heavy atom 
count color coding was used for the MQN map (a), SMIfp map (b), APfp map (c) and Xfp map (d), while the N–C=C substructure cound is used for 
Sfp (e). Four of the 20 selected drugs are shown in e
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a starting point. Duplicates and molecules larger than 50 
heavy atoms were removed from the database.
Fingerprints Calculation of MQN, SMIfp, APfp and Xfp 
fingerprints are discussed in detail in the respective pub-
lications from our group. Fingerprints were calculated as 
described previously using plugins provided in JChem 
chemistry library.
Principal component analysis
The PCA for each database was performed using an in 
house written Java program utilizing some of the avail-
able mathematical functions from JSci (A science API for 
Java: http://jsci.sourceforge.net/). The Java source code 
is based on the tutorial of Lindsay I. Smith (http://www.
cs.otago.ac.nz/cosc453/student_tutorials/principal_com-
ponents.pdf ).
3D‑space and color coding
The PC-1, PC-2 and PC-3 values were calculated for 
each molecule in the database. The largest (PCmax) and 
smallest (PCmin) PC values appearing in the PC-1 or 
PC-2 or PC-3 values were used to define the value range 
ΔPC  =  PCmax  −  PCmin and set the binning scale as 
ΔPC/300. The PC-1, PC-2 and PC-3 values were binned 
onto 300 × 300 × 300 3D-grids using the same absolute 
bin size on the PC-1, PC-2 and PC-3 axis. Each molecule 
was assigned to a point on this 3D-grid. The Hue–Satura-
tion–Lightness (HSL) color space was used for color cod-
ing, setting the hue value according to the average value 
of the selected molecular property across all molecules 
residing at that grid point, and the saturation according 
to the standard deviation of that value across all mol-
ecules within ±5 grid points in each direction. As a result 
the color change blue–cyan–green–yellow–red–magenta 
shows an increasing average value of property in a grid 
point, and saturation to grey indicates a strong gradient 
of the value in the vicinity.
webDrugCS
The core part of webDrugCS for 3D-rendering and vis-
ualization is supported by the Three.js (http://threejs.
org/), an open-source JavaScript library/API to create 
and display animated 3D computer graphics in a web 
browser. Three.js uses WebGL and runs across various 
browsers without need for any additional plugins. The 
webDrugCS has been successfully tested on IE, Chrome 
and Opera browsers. The only requirement for the web-
DrugCS is to have JavaScript enabled in a web browser. 
The source code of the webDrugCS visualizer is available 
for download at https://github.com/mahendra-awale/
webDrugCS.
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